These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 19452403

  • 1. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.
    Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M.
    Semin Thromb Hemost; 2009 Apr; 35(3):277-87. PubMed ID: 19452403
    [Abstract] [Full Text] [Related]

  • 2. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG.
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [Abstract] [Full Text] [Related]

  • 3. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S, Younossi ZM.
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [Abstract] [Full Text] [Related]

  • 4. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review.
    Salt WB.
    J Insur Med; 2004 Jun; 36(1):27-41. PubMed ID: 15104027
    [Abstract] [Full Text] [Related]

  • 5. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 6. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N, Younossi ZM.
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [Abstract] [Full Text] [Related]

  • 7. From the metabolic syndrome to NAFLD or vice versa?
    Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G.
    Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C and nonalcoholic fatty liver disease.
    Ramesh S, Sanyal AJ.
    Semin Liver Dis; 2004 Nov; 24(4):399-413. PubMed ID: 15605308
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
    Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C.
    J Nutr Biochem; 2007 Mar; 18(3):184-95. PubMed ID: 17296492
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J, Torok N.
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [Abstract] [Full Text] [Related]

  • 13. Nonalcoholic fatty liver disease.
    Hjelkrem MC, Torres DM, Harrison SA.
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [Abstract] [Full Text] [Related]

  • 14. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G, Babini M.
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [Abstract] [Full Text] [Related]

  • 15. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C, Younossi ZM.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications.
    Targher G, Byrne CD.
    Semin Thromb Hemost; 2013 Mar; 39(2):214-28. PubMed ID: 23397556
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H, Daram SR.
    Postgrad Med; 2008 Jul 31; 120(2):E01-7. PubMed ID: 18654060
    [Abstract] [Full Text] [Related]

  • 20. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Apr 31; 103(4):1036-42. PubMed ID: 18177455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.